Literature DB >> 20430221

Effects of cyclosporine on the antioxidant status and oxidative stress in the glioma cells.

K H Mun1, E Y Ha.   

Abstract

OBJECTIVES: After organ transplantation, some patients suffer neurological complications. Among the immunosuppressants, cyclosporine can cause neurological side effects. However, the mechanisms of encephalopathy by cyclosporine are not fully understood. We measured the antioxidant status, the hydrogen peroxide level, and the malondialdehyde level in glioma cells after cyclosporine treatment.
METHODS: The production of hydrogen peroxide was determined using a modified xylenol orange method. The amount of malondialdehyde was measured using the thiobarbituric acid assay. Total antioxidant status was measured using Free Radical Analytical System 4 with kits.
RESULTS: Cyclosporine resulted in the production of hydrogen peroxide by the glioma cells. The increased production of hydrogen peroxide depended on the drug concentration. The antioxidant status was decreased in the glioma cells after cyclosporine treatment. The malondialdehyde level was not changed in glioma cells after cyclosporine treatment.
CONCLUSIONS: Increased production of reactive oxygen species and decreased antioxidant status by cyclosporine in glioma cells may contribute to neurological side effects in transplantation patients. Copyright (c) 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20430221     DOI: 10.1016/j.transproceed.2010.03.015

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Neuroprotective effects of Tacrolimus (FK-506) and Cyclosporin (CsA) in oxidative injury.

Authors:  Seema Yousuf; Fahim Atif; Varun Kesherwani; Sandeep Kumar Agrawal
Journal:  Brain Behav       Date:  2011-11       Impact factor: 2.708

2.  Effect of cyclosporine-a on paraoxonase activity in wistar rats.

Authors:  H Argani; A Ghorbanihaghjo; N Rashtchizadeh; S Seifirad; Y Rahbarfar
Journal:  Int J Organ Transplant Med       Date:  2011
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.